LEXARIA BIOSCIENCE CORP. Gain (Loss) on Disposition of Assets
LEXARIA BIOSCIENCE CORP. (LEXX) reported Gain (Loss) on Disposition of Assets of $1.52 million for the 12-month period ending 2022-08-31, per its 10-K filed 2022-11-28.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2022-11-28
- LEXARIA BIOSCIENCE CORP. gain (loss) on disposition of assets for the quarter ending 2022-08-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. gain (loss) on disposition of assets for the quarter ending 2022-05-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. gain (loss) on disposition of assets for the quarter ending 2022-02-28 was $1.52M.
- LEXARIA BIOSCIENCE CORP. gain (loss) on disposition of assets for the quarter ending 2021-11-30 was $0.00.
- LEXARIA BIOSCIENCE CORP. gain (loss) on disposition of assets for fiscal 2022 was $1.52M, a 0.00% change from fiscal 2021.
- LEXARIA BIOSCIENCE CORP. gain (loss) on disposition of assets for fiscal 2021 was $1.52M.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 15 month |
|---|---|---|---|---|---|
| 2022-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $0.00 derived: sum of 2 quarters · filed 2022-11-28 | $1.52M derived: sum of 3 quarters · filed 2022-11-28 | $1.52M 10-K · filed 2022-11-28 | |
| 2022-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | $1.52M derived: sum of 2 quarters · filed 2022-11-28 | $1.52M 10-Q · filed 2022-07-14 | $1.52M derived: sum of 4 quarters · filed 2022-11-28 | |
| 2022-02-28 | $1.52M derived: 10-K 12 month − 3 quarters · filed 2022-11-28 | $1.52M 10-Q · filed 2022-04-11 | $1.52M derived: sum of 3 quarters · filed 2022-11-28 | $1.52M derived: sum of 4 quarters · filed 2022-11-28 | |
| 2021-11-30 | $0.00 derived: 10-Q 15 month − 10-K 12 month · filed 2022-01-14 | $0.00 derived: sum of 2 quarters · filed 2022-01-14 | $0.00 derived: sum of 3 quarters · filed 2022-01-14 | $1.52M 10-Q · filed 2022-01-14 | |
| 2021-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $0.00 derived: sum of 2 quarters · filed 2021-11-29 | $1.52M 10-K · filed 2021-11-29 | ||
| 2021-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-15 | $1.52M 10-Q · filed 2021-07-15 | |||
| 2021-02-28 | $1.52M 10-Q · filed 2021-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |